TheEdgeResearch
Home / Stocks / MEDVF

Medivolve Inc. (MEDVF)

OTC Healthcare Medical - Diagnostics & Research
$0.00 ▲ +0.00%
Market Cap
$2,702
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
2.73
52-Wk Range
0.0001-0.002
CEO
Neil Said
Country
CA
Currency
USD

Medivolve Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2,702. On trailing twelve-month figures it carries a trailing P/E of -0.21, a net margin of -2397.5%. Its beta of 2.73 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.21
Price / Sales
1.18
Price / Book
-0.05
EV / EBITDA
-0.61
Gross margin
78.3%
Operating margin
-521.5%
Net margin
-2397.5%
Return on equity
—
Debt / equity
-0.11
Current ratio
0.08
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
25
IPO date
2009-12-18
Headquarters
Toronto, ON, CA
About Medivolve Inc.

Medivolve Inc. operates as a principal investment firm, primarily targeting opportunities within the healthcare technology, industrial, and information technology sectors. Established in 2005 and based in Toronto, Canada, the company was previously known as QuestCap Inc.

Comparable companies

Medivolve Inc. is most often compared with the following Healthcare names:

BIOIFCBGLCEOSIMMBINSDLADXLRDSFMHTXOPGXOWCP
More research on MEDVF
MEDVF technical analysis MEDVF TheEdge Score Compare against peers
Open full interactive analysis & DCF →